Xbiome Alternatives & Competitors
12 companies similar to Xbiome — China's leading AI-driven microbiome drug development company
Companies similar to Xbiome
iLOF
Using AI and Photonics to enable a new era of personalized, precision medicine.
London, United Kingdom
Parallel Bio
Using the immune system to cure disease.
Watertown, United States
Diffuse Bio
We build generative AI for protein therapeutics.
MYCB1 Group B.V.
MYCB1 Group B.V. produces, and distributes GMP-grade cannabinoid medicines via its German...
Amsterdam, The Netherland...
Track all Xbiome competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
MetaGenomika
A knowledge-based company focused on developing AI-powered Molecular Diagnostics for chron...
Seattle, United States
DeepCure
Reimagining small molecule therapies for immune diseases
Boston, United States
FatiAbGen Inc.
Best in class multi-modality antibodies for difficult targets in high unmet need diseases...
Korea South
PreBiomics
Our mission is to build the world largest platform for the oral microbiome
Italy
Antiverse
Designing functional antibodies for the most challenging targets.
Cardiff, United Kingdom
Eli Lilly and Company
Discovery, development, manufacture, and sale of products in pharmaceutical products busin...
Indianapolis, United Stat...
-logo.jpg "Lantern Pharma Inc. (Nasdaq: LTRN)"){kind=logo}
Lantern Pharma Inc. (Nasdaq: LTRN)
Leveraging Artificial Intelligence to Rescue and Develop Cancer Therapies
Dallas, United States
About Xbiome
Xbiome, established in 2017, is touted as China's leading AI-driven microbiome drug development company. As a pioneer in AI-based solutions, it aims to transform the biotechnology and pharmaceutical sectors, focusing on gut microbiome using sophisticated AI techniques. This approach to health leverages the gut's microb...
Technology Platform Development, Pharmaceutical Research, Drug Pipeline Management, Collaboration with Scientific and Medical Communities
Biotech and Pharma Companies, Healthcare Organizations, Research Institutions, Scientific Community
AI-driven Drug Development, Microbiome Therapeutics, Gut Health Management, Personalized Medicine, Bioinformatics, Microbial Technology, Intestinal Micro-ecology, Pharmaceutical Innovation, Dysbiosis Solutions, Microbiota Analysis, Artificial Intelligence In Healthcare, Precision Health, Microbial Ecosystem Analysis, Human Microbiome
B2B, Platform, SaaS
Licensing, Performance Based, Subscription
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Xbiome and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Xbiome on 15 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 1 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
